Despite meningitis outbreak, some hospitals have little choice but to rely on compounding pharmacies. Many hospitals will continue to use compounding pharmacies for hard-to-obtain drugs because they have no alternative, even though a deadly meningitis outbreak traced to a compounding facility has raised grave concerns about safety and oversight.
As of Oct. 12, at least 184 people in 12 states had contracted fungal meningitis after receiving tainted steroid injections from the New England Compounding Center, according to the Centers for Disease Control and Prevention. Fourteen had died.
Read the full story: http://bit.ly/QHq9Oa
Source: Modern Healthcare
Value-Based Primary Care Providers Try New Strategies to Improve Population Health
December 15th 2022The dilemma of Alzheimer disease in primary care, as well as other health challenges in aging populations, was the focus of a recent Institute for Value-Based Medicine® event in Portland, Oregon.
Read More
Primary Care During COVID-19: Looking at Payer, Provider Cooperation
January 4th 2022On this episode of Managed Care Cast, we bring you part 1 of an 8-part video conversation with Blue Cross Blue Shield of North Carolina and Newton Family Physicians about how they adapted to deliver health care in 2020 and 2021.
Listen
Growing Innovation, Cost Expected in the Oncology Drug Pipeline
October 15th 2022The concluding keynote address at the Academy of Managed Care Pharmacy Nexus 2022 meeting discussed new and emerging oncology drugs in the pipeline and their potential impact on the treatment landscape as it pertains to managed care providers.
Read More
AMCP Nexus 2022 to Address Evolving Value-Based Frameworks, Shared Decision-Making
October 10th 2022The annual fall meeting of AMCP Nexus 2022 will feature a keynote from one of the top physician-executives in health care, the specialty pharmaceutical pipeline, and insights for managed care stakeholders in selecting and integrating cost-effective, value-based care frameworks.
Read More
2 Clarke Drive
Cranbury, NJ 08512